Thomas Flaten
Stock Analyst at Lake Street
(4.44)
# 1,131
Out of 4,468 analysts
331
Total ratings
51.7%
Success rate
10%
Average return
Main Sectors:
Stocks Rated by Thomas Flaten
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HROW Harrow | Maintained: Buy | $60 | $42.74 | +40.38% | 19 | Jul 1, 2026 | |
| DMAC DiaMedica Therapeutics | Reiterated: Buy | $14 | $7.62 | +83.73% | 23 | Jun 23, 2026 | |
| RPID Rapid Micro Biosystems | Maintained: Buy | $8 → $7 | $1.72 | +306.98% | 8 | May 22, 2026 | |
| AQST Aquestive Therapeutics | Maintained: Buy | $6 | $4.18 | +43.54% | 36 | May 15, 2026 | |
| IMDX Insight Molecular Diagnostics | Maintained: Buy | $12 | $5.74 | +109.06% | 23 | May 14, 2026 | |
| AYTU Aytu BioPharma | Maintained: Buy | $8 → $7 | $2.16 | +224.07% | 6 | May 14, 2026 | |
| MDXH MDxHealth | Maintained: Buy | $9 → $5 | $0.4765 | +949.32% | 14 | May 14, 2026 | |
| DERM Journey Medical | Maintained: Buy | $13 | $7.08 | +83.62% | 15 | May 14, 2026 | |
| BLFS BioLife Solutions | Maintained: Buy | $33 | $28.11 | +17.40% | 25 | May 8, 2026 | |
| ARLO Arlo Technologies | Reiterated: Buy | $24 | $12.98 | +84.90% | 1 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $9 | $3.41 | +163.93% | 24 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $52 | $24.11 | +115.68% | 24 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $40 | $21.99 | +81.90% | 14 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $14 | $5.60 | +150.00% | 1 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $11 | $6.40 | +71.88% | 30 | Apr 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $9 | $2.46 | +265.85% | 2 | Apr 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $50 | $25.77 | +94.02% | 5 | Mar 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $11 | $13.62 | -19.24% | 27 | Feb 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $9.60 | n/a | 15 | May 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $1.5 | $0.0001 | n/a | 8 | Nov 29, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $96 → $15 | $0.284 | n/a | 3 | Apr 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $3.5 | $2.08 | n/a | 4 | Sep 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $60 → $50 | $57.08 | n/a | 4 | Mar 1, 2022 |
Harrow
Jul 1, 2026
Maintained: Buy
Price Target: $60
Current: $42.74
Upside: +40.38%
DiaMedica Therapeutics
Jun 23, 2026
Reiterated: Buy
Price Target: $14
Current: $7.62
Upside: +83.73%
Rapid Micro Biosystems
May 22, 2026
Maintained: Buy
Price Target: $8 → $7
Current: $1.72
Upside: +306.98%
Aquestive Therapeutics
May 15, 2026
Maintained: Buy
Price Target: $6
Current: $4.18
Upside: +43.54%
Insight Molecular Diagnostics
May 14, 2026
Maintained: Buy
Price Target: $12
Current: $5.74
Upside: +109.06%
Aytu BioPharma
May 14, 2026
Maintained: Buy
Price Target: $8 → $7
Current: $2.16
Upside: +224.07%
MDxHealth
May 14, 2026
Maintained: Buy
Price Target: $9 → $5
Current: $0.4765
Upside: +949.32%
Journey Medical
May 14, 2026
Maintained: Buy
Price Target: $13
Current: $7.08
Upside: +83.62%
BioLife Solutions
May 8, 2026
Maintained: Buy
Price Target: $33
Current: $28.11
Upside: +17.40%
Arlo Technologies
May 8, 2026
Reiterated: Buy
Price Target: $24
Current: $12.98
Upside: +84.90%
May 8, 2026
Maintained: Buy
Price Target: $9
Current: $3.41
Upside: +163.93%
May 7, 2026
Maintained: Buy
Price Target: $52
Current: $24.11
Upside: +115.68%
May 5, 2026
Maintained: Buy
Price Target: $40
Current: $21.99
Upside: +81.90%
May 5, 2026
Reiterated: Buy
Price Target: $14
Current: $5.60
Upside: +150.00%
Apr 15, 2026
Maintained: Buy
Price Target: $11
Current: $6.40
Upside: +71.88%
Apr 1, 2026
Maintained: Buy
Price Target: $9
Current: $2.46
Upside: +265.85%
Mar 25, 2026
Reiterated: Buy
Price Target: $50
Current: $25.77
Upside: +94.02%
Feb 27, 2026
Maintained: Buy
Price Target: $11
Current: $13.62
Upside: -19.24%
May 15, 2025
Maintained: Hold
Price Target: n/a
Current: $9.60
Upside: n/a
Nov 29, 2023
Maintained: Buy
Price Target: $1.5
Current: $0.0001
Upside: n/a
Apr 12, 2023
Maintained: Buy
Price Target: $96 → $15
Current: $0.284
Upside: n/a
Sep 16, 2022
Maintained: Buy
Price Target: $3.5
Current: $2.08
Upside: n/a
Mar 1, 2022
Maintained: Buy
Price Target: $60 → $50
Current: $57.08
Upside: n/a